7.790USD-2.01%Mkt Cap: 143.03M USDP/E: —Last update: 2026-06-01
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of N…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap143.03M USD
Enterprise Value3.30M USD
Revenue (TTM)—
Gross Profit-70.09M USD
Net Income (TTM)-78.54M USD
Revenue/Share—
Last Price7.790 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees36
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINLU1829218749
Valuation
P/E (Trailing)—
P/E (Forward)-1.56
PEG—
EV/EBITDA-0.04
EV/Revenue—
P/S—
P/B1.11
EPS (TTM)-5.74
EPS (Forward)-5.07
52W Range
6.7208% of range20.56
52W High20.56 USD
52W Low6.720 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.24%
ROA-46.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-64.49M USD
CapEx (TTM)7.00K USD
FCF Margin—
FCF Yield—
Net Debt-137.01M USD
Net Debt/EBITDA1.53
Balance Sheet
Debt/Equity0.01
Current Ratio7.92
Quick Ratio7.62
Book Value/Sh7.122 USD
Cash/Share7.792 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateFeb 14, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)36.50 USD
Target Range17.00 USD – 54.00 USD
# Analysts10
Ownership
Shares Out.18.53M
Float12.74M
Insiders1.00%
Institutions72.00%
Short Interest
Short Ratio3.9d
Short % Float7.43%
Short % Out.6.45%
Shares Short1.20M
Short (prev mo.)1.34M
Technical
SMA 509.931 (-21.6%)
SMA 20010.36 (-24.8%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)500.77K
Avg Vol (10d)918.17K
Technical Indicators
RSI (14)37.6
MACD-0.4949
MACD Signal-0.0877
MACD Hist.-0.4072
BB Upper13.11 USD
BB Middle10.24 USD
BB Lower7.363 USD
BB Width56.16%
ATR (14)0.9852 USD
Vol Ratio (20d)1.37x